Mirum Pharmaceuticals Inc (NASDAQ:MIRM) does about 510.82K shares in volume on a normal day but saw 3590296 shares change hands in Monday trading. The company now has a market cap of 1.56B USD. Its current market price is $33.00, marking an increase of 27.31% compared to the previous close of $25.92. The 52 week high reached by this stock is $35.56 whilst the lowest price level in 52 weeks is $23.14.
Mirum Pharmaceuticals Inc (MIRM) has a 20-day trading average at $25.83 and the current price is -7.20% off the 52-week high compared with 42.61% distance from its 52-week low. The 50-day simple moving average of the closing price is $25.28 and its 200-day simple moving average is $28.06. If we look at the stock’s price movements over the week, volatility stands at 8.46%, which decreases to 5.35% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 75.85 to suggest the stock is overbought.
The consensus objective for the share price is $49.73, suggesting that the stock has a potential upside of 33.64% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 17, 2024 when Stifel initiated the stock to “Buy” and issued a price target of $48. JP Morgan resumed its price target at $37.
Mirum Pharmaceuticals Inc (MIRM) stock is up 29.16% over the week and 33.33% over the past month. Its price is 11.79% year-to-date and 17.48% over the past year.
To reach the target analysts have set, the stock logically needs to grow 33.64 percent from here.
The company has a return on investment of -28.80% and return on equity of -83.06%. The beta has a value of 1.10. Price to book ratio is 6.62 and price to sales ratio is 6.94.
